| |
 | |  |
|
| |
|
Herbal Extract Inhibits Development Of Pancreatic Cancer
(20/Apr/2009)
|
|
An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to new research. (Source: ScienceDaily Headlines)
|
|
|
New Drug Achieves Pancreatic Cancer Tumor Remission And Prevents Recurrence, Study Suggests
(20/Apr/2009)
|
|
Pancreatic cancer remains one of the deadliest cancers, but researchers may have found a combination therapy to reduce cancer stem cells and stop pancreatic cancer growth. Treatment with gemcitabine and tigatuzumab resulted in the reduction of pancreatic cancer stem cells, caused tumor remission, and significantly increased time-to-tumor progression in 50 percent of treated cases from a median of 54 days to 103 days. (Source: ScienceDaily Headlines)
|
|
|
AACR: Drug Combo Effective Against Pancreatic Cancer Cells
(20/Apr/2009)
|
|
DENVER (MedPage Today) -- A combination of two targeted therapies can kill cells from pancreatic cancer, holding out the possibility of new treatments for the deadly disease, a Minnesota researcher said here. (Source: MedPage Today Hematology/Oncology)
|
|
|
Herbal Extract Inhibits The Development Of Pancreatic Cancer
(20/Apr/2009)
|
|
An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver. (Source: Health News from Medical News Today)
|
|
|
Mayo Clinic researchers formulate treatment combination lethal to pancreatic cancer cells
(19/Apr/2009)
|
|
(Mayo Clinic) A combination of two targeted therapies packs a powerful punch to kill pancreatic cancer cells in the laboratory, Mayo Clinic cancer researchers report. With further testing of these drugs that are from classes of pharmaceuticals already used in patients, the Mayo research may lead to new treatment opportunities for patients with pancreatic cancer, which is extremely difficult to treat. (Source: EurekAlert! - Cancer)
|
|
|
Pancreatic cancer therapy 'hope'
(18/Apr/2009)
|
|
A drug designed by UK researchers to prevent tumour growth has shown promise on pancreatic and lung cancer. (Source: BBC News | Health | UK Edition)
|
|
|
Epidermal growth factor receptor active in human pancreatic cancers
(18/Apr/2009)
|
|
Finally some promising news about pancreatic cancer, one of the most fatal cancers, due to the difficulties of early detection and the lack of effective therapies: Johns Hopkins University pathologist Akhilesh Pandey has identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic cancers studied. (Source: Huliq Health News)
|
|
|
Pancreatic Cancer Biomarkers List Created
(18/Apr/2009)
|
|
BALTIMORE -- A Johns Hopkins University scientist has created a compendium of 50,000 possible pancreatic cancer biomarkers and says he's asked his colleagues to study it. Associate Professor Dr. Akhilesh Pandey, founder and director of the Institute of Bioinformatics in Bangalore, India, said with limited resources available for the testing needed to be considered a bona fide biomarker of clinical value, it's important to take stock of the big picture and come up with strategies. Pandey
|
|
|
Cause for hope in cystic fibrosis
(18/Apr/2009)
|
|
A team of British scientists is on the verge of a revolutionary treatment for cystic fibrosis that could extend patients' life by decades. Robin McKie meets the researchers and patients involved in a groundbreaking advance against cystic fibrosisIn the downstairs hall of Katrina and Mark Dujardin's elegant Cambridge house, there is a cupboard that would do justice to a professional pharmacy. From floor to ceiling, its shelves are lined with cellophane-wrapped boxes of antibiotics, jars of
|
|
|
Clavis Pharma Initiates Phase II Clinical Study Of Intravenous CP-4126 In Patients With Advanced Pancreatic Cancer
(17/Apr/2009)
|
|
Clavis Pharma ASA (OSE: CLAVIS) announced initiation of the first phase II study with Intravenous CP-4126 (a novel Lipid Vector Technology analogue of gemcitabine) in patients with newly diagnosed, advanced pancreatic cancer. The standard treatment for advanced pancreatic cancer is currently gemcitabine (Gemzar®). (Source: Health News from Medical News Today)
|
|
|
Can EUS Elastography Help Distinguish Benign From Malignant Tissue?
(17/Apr/2009)
|
|
A major limitation of endoscopic ultrasound (EUS) examination is its limited capacity to determine the exact nature of a lesion. The differential diagnosis between benign and malignant lymph nodes and focal pancreatic masses based on the EUS appearance is difficult and frequently requires EUS-guided fine needle aspiration (EUS-FNA) for confirmation of malignancy. (Source: Health News from Medical News Today)
|
|
|
Experimental Insulin-Like Growth Factor Receptor Inhibitor Reduced Pancreatic Cancer Growth
(17/Apr/2009)
|
|
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics , a journal of the American Association for Cancer Research. (Source: Health News from Medical News Today)
|
|
|
A Phase I Clinical Trial Of ImmuFact IMP321 In Pancreatic Cancer Has Started At Washington University In Saint Louis (MO)
(17/Apr/2009)
|
|
Immutep S.A. announced the first administration of IMP321 in pancreatic cancer patients in a Phase I trial conducted by Dr. William G. Hawkins at the Washington University School of Medicine in Saint Louis (MO). IMP321 is a first-in-class immunopotentiator that stimulates antigen-presenting cells (APC), such as dendritic cells and monocytes, leading to markedly improved cytotoxic CD8 T cells responses against tumours in patients. (Source: Cancer / Oncology News From Medical News Today)
|
|
|
Pineapple Compound Treats Cancer, Inflammation and Poor Digestion
(16/Apr/2009)
|
|
(NaturalNews) Nothing brings up the images of summer breezes and relaxation like pineapple, the sweet juicy treat from the tropics. While thoughts of fun in the sun ease the mind, eating pineapple can greatly ease the body. Bromelain, the key enzyme in pineapple, banishes inflammation as effectively as drugs. It reduces swelling, helps against sore throat, treats arthritis and gout, and speeds digestion of proteins. New research is even showing pineapple to be highly effective at
|
|
|
Findings show insulin - not genes - linked to obesity
(15/Apr/2009)
|
|
Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin. (2009-04-15)
|
|
|
New Pancreatic Cancer Drug in the Works
(14/Apr/2009)
|
|
An experimental drug called AMG 479 shows promise against pancreatic cancer in early lab tests, researchers report. (Source: WebMD Health)
|
|
|
Stem cells can treat type 1 diabetes
(14/Apr/2009)
|
|
A pioneering treatment that uses stem cell injections to reset a patient's immune system can help people with type 1 diabetes go for several years without needing insulin injections. However, the treatment has risks, and doesn't seem to work for everyone.What do we know already?In 2007, doctors announced early trials of an exciting new treatment which could potentially reverse the effects of type 1 diabetes. After receiving a transplant of their own stem cells combined with
|
|
|
Device Protects Transplanted Pancreatic Cells from the Immune System
(10/Apr/2009)
|
|
Scientists at Burnham Institute for Medical Research (Burnham) and the University of California San Diego (UC San Diego) School of Medicine have demonstrated in mice that transplanted pancreatic precursor cells are protected from the immune system when encapsulated in polytetrafluorethylene (PTFE). (2009-04-10)
|
|
|
New Technique Reveals Pancreatic Stem Cells
(10/Apr/2009)
|
|
Wanted: stems cells. Just like those absconders chased by police all over the world, everybody can tell about their good deeds but none really knows how to recognize them. Yet, thanks to a study published in the Proceedings of the National Accademy of Sciences (PNAS) and authored by Nobel Laureate for Medicine in 2007 Mario Capecchi and by the researcher from the Catholic University of Rome Eugenio Sangiorgi, we now know how to reveal the stem
|
|
|
Compendium of Pancreatic Cancer Biomarkers Established as Strategic Approach to Early-Detection Research- 4/6/09
(09/Apr/2009)
|
|
A cancer scientist from Johns Hopkins has convinced an international group of colleagues to delay their race to find new cancer biomarkers and instead begin a 7,000-hour slog through a compendium of 50,000 scientific articles already published to assemble, decode and analyze the molecules that might herald the furtive presence of pancreatic cancer. (Source: Johns Hopkins Medicine News)
|
|
| |
| | |
|
